German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Kim Magaly Pabst in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
Search for other papers by Robert Seifert in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Nader Hirmas in
Google Scholar
PubMed
Search for other papers by Martina Broecker-Preuss in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Manuel Weber in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Wolfgang Peter Fendler in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Timo Bartel in
Google Scholar
PubMed
Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany
Search for other papers by Sarah Theurer in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Ken Herrmann in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Current guidelines for differentiated thyroid carcinoma (DTC) ( 1 , 2 ) assign a crucial diagnostic importance to stimulated thyroglobulin (s-Tg) measurement 6–12 months after completion of primary therapy to predict a recurrence-free follow-up than in
Search for other papers by Teresa Kraus in
Google Scholar
PubMed
Search for other papers by Natalia Shengelia-de Lange in
Google Scholar
PubMed
Search for other papers by Holger Einspieler in
Google Scholar
PubMed
Search for other papers by Marcus Hacker in
Google Scholar
PubMed
Search for other papers by Alexander Haug in
Google Scholar
PubMed
Search for other papers by Elisabeth Kretschmer-Chott in
Google Scholar
PubMed
Search for other papers by Georgios Karanikas in
Google Scholar
PubMed
Augello G D’Aloiso L Bonfitto N Varraso A Dicembrino F Modoni S Frusciante V Giorgio AD , et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck
Search for other papers by Sara Ahmadi in
Google Scholar
PubMed
Search for other papers by Alexandra Coleman in
Google Scholar
PubMed
Endocrinology Service, Instituto Nacional de Câncer, Rio de Janeiro, Brazil
Search for other papers by Nathalie Silva de Morais in
Google Scholar
PubMed
Search for other papers by Iñigo Landa in
Google Scholar
PubMed
Search for other papers by Theodora Pappa in
Google Scholar
PubMed
Search for other papers by Alex Kang in
Google Scholar
PubMed
Search for other papers by Matthew I Kim in
Google Scholar
PubMed
Search for other papers by Ellen Marqusee in
Google Scholar
PubMed
Search for other papers by Erik K Alexander in
Google Scholar
PubMed
, stimulated thyroglobulin (Tg) was available in 43 (40%) patients (mean Tg = 15.8, s.d. 9.4), while 51 (47%) patients had positive thyroglobulin antibodies. In the SPECT-CT cohort, stimulated thyroglobulin was available in 63 (60%) patients (mean 9.1, s
Search for other papers by Danuta Gąsior-Perczak in
Google Scholar
PubMed
Search for other papers by Iwona Pałyga in
Google Scholar
PubMed
Search for other papers by Monika Szymonek in
Google Scholar
PubMed
Search for other papers by Artur Kowalik in
Google Scholar
PubMed
Search for other papers by Agnieszka Walczyk in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Katarzyna Lizis-Kolus in
Google Scholar
PubMed
Search for other papers by Anna Słuszniak in
Google Scholar
PubMed
Search for other papers by Janusz Słuszniak in
Google Scholar
PubMed
Search for other papers by Tomasz Łopatyński in
Google Scholar
PubMed
Search for other papers by Ryszard Mężyk in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
.1371/journal.pone.0153242 27078258 16 Kowalska A Pałyga I Gąsior-Perczak D Walczyk A Trybek T Słuszniak A Mężyk R Góźdź S . The cut-off level of recombinant human TSH-stimulated thyroglobulin in the follow-up of patients with
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital/ University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by S C Clement in
Google Scholar
PubMed
Search for other papers by W E Visser in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C A Lebbink in
Google Scholar
PubMed
Search for other papers by D Albano in
Google Scholar
PubMed
Search for other papers by H L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by A Czarniecka in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Search for other papers by R P Dias in
Google Scholar
PubMed
Search for other papers by M P Dierselhuis in
Google Scholar
PubMed
Search for other papers by I Dzivite-Krisane in
Google Scholar
PubMed
Search for other papers by R Elisei in
Google Scholar
PubMed
Search for other papers by A Garcia-Burillo in
Google Scholar
PubMed
Search for other papers by L Izatt in
Google Scholar
PubMed
Search for other papers by C Kanaka-Gantenbein in
Google Scholar
PubMed
Search for other papers by H Krude in
Google Scholar
PubMed
Search for other papers by L Lamartina in
Google Scholar
PubMed
Search for other papers by K Lorenz in
Google Scholar
PubMed
Search for other papers by M Luster in
Google Scholar
PubMed
Search for other papers by R Navardauskaitė in
Google Scholar
PubMed
Search for other papers by M Negre Busó in
Google Scholar
PubMed
Search for other papers by K Newbold in
Google Scholar
PubMed
Search for other papers by R P Peeters in
Google Scholar
PubMed
Search for other papers by G Pellegriti in
Google Scholar
PubMed
Search for other papers by A Piccardo in
Google Scholar
PubMed
Search for other papers by A L Priego in
Google Scholar
PubMed
Search for other papers by A Redlich in
Google Scholar
PubMed
Search for other papers by L de Sanctis in
Google Scholar
PubMed
Search for other papers by M Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by A S P van Trotsenburg in
Google Scholar
PubMed
Search for other papers by F A Verburg in
Google Scholar
PubMed
Search for other papers by M Vriens in
Google Scholar
PubMed
Search for other papers by T P Links in
Google Scholar
PubMed
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK
Office for Rare Conditions, University of Glasgow, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
Tsagarakis S . Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence . Endocrine 2020 70 566 – 574
Search for other papers by Norra Kwong in
Google Scholar
PubMed
Search for other papers by Ellen Marqusee in
Google Scholar
PubMed
Division of Endocrinology, Endocrine Division, Hypertension and Diabetes, Thyroid Section, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue Boston, Massachusetts 02115, USA
Search for other papers by Michael S Gordon in
Google Scholar
PubMed
Search for other papers by P Reed Larsen in
Google Scholar
PubMed
Division of Endocrinology, Endocrine Division, Hypertension and Diabetes, Thyroid Section, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue Boston, Massachusetts 02115, USA
Search for other papers by Jeffrey R Garber in
Google Scholar
PubMed
Search for other papers by Matthew I Kim in
Google Scholar
PubMed
Search for other papers by Erik K Alexander in
Google Scholar
PubMed
-sectional imaging. Stimulated thyroglobulin ranged from 1.9 to 2.5 ng/ml over the first 6 years, though was once reported as undetectable. However, she later developed anti-thyroglobulin antibodies, which have since persisted. At the age of 40, PET scanning revealed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
according to 2015 ATA guidelines ( 7 ). The patients followed a low-iodine diet for 3–4 weeks and thyroid hormone withdrawal at least 3 weeks before 131 I therapy. The oral 131 I dose depended on the postoperative risk stratification and stimulated
Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Thomas Crezee in
Google Scholar
PubMed
Search for other papers by Mirela Petrulea in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Doina Piciu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Jan W A Smit in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Theo S Plantinga in
Google Scholar
PubMed
Endocrinology Clinic, Cluj County Emergency Hospital, Cluj-Napoca, Romania
Search for other papers by Carmen E Georgescu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
stimulated thyroglobulin (Tg, <1 pmol/L in the Dutch patients and <0.04 ng/mL in the Romanian patients) in the absence of anti-Tg antibodies and no evidence of loco-regional disease or distant metastasis on the whole body iodine scans (WBS) and/or neck
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Catarina Tavares in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Institute of Biomedical Sciences of Abel Salazar (ICBAS), Porto, Portugal
Search for other papers by Maria João Coelho in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Catarina Eloy in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, University and Hospital Center of Coimbra, Coimbra, Portugal
Medical Faculty, University of Coimbra, Coimbra, Portugal
Search for other papers by Miguel Melo in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Public Health Unit, ACeS Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Ana Pestana in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Rui Batista in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Luciana Bueno Ferreira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Hospital de S. João, Porto, Portugal
Search for other papers by Elisabete Rios in
Google Scholar
PubMed
Search for other papers by Samia Selmi-Ruby in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Institute of Biomedical Sciences of Abel Salazar (ICBAS), Porto, Portugal
Search for other papers by Bruno Cavadas in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Hospital de S. João, Porto, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
protocols available at the time. Data regarding the number of radioiodine treatments and cumulative activity were retrieved from hospital records. Patients were considered as being disease-free at the end of follow-up if they had undetectable stimulated